Hugh M. Davis Chief Business Officer, Frontage Laboratories, Inc., Exton, Pennsylvania (PA, USA) As CBO for Frontage Laboratories, Dr Davis…
We talk to Vellalore Kakkanaiah about his work using flow cytometry in adoptive cell therapy in this interview as part of our author’s perspective series.
In this Bioanalysis Zone interview, Pegah Jalili (MilliporeSigma) discusses her current work in analytical R&D of biotherapeutic characterization and quantification, and what she thinks the future looks like for this field of bioanalysis.
We talk to Zhengqi Ye about the approaches she uses to measure protein binding of enzymatically unstable compounds in plasma in this interview as part of our author’s perspective series.
We talk to Laura Rowe about her work using UHPLC to analyse protein glycosylation in this interview as part of our author’s perspective series.
In this interview, Laura Mercolini (University of Bologna) discusses the advantages and disadvantages of using volumetric absorptive microsampling (VAMS) as a bioanalytical tool, touching upon her recent paper on the same topic.
We talk to Wenying Jian about her work on the quantitation of total Centyrin protein using liquid chromatography–tandem mass spectrometry in this interview as part of our author’s perspective series.
We celebrate Chinese New Year by interviewing Fan Jin (Covance; NJ, USA), who discusses the history, background and aims behind the China Bioanalytical Forum.
We talk to Amanda King-Ahmad about her work on the peptide-based glucagon-like peptide-1 receptor agonist liraglutide in this interview as part of our author’s perspective series.
In this Bioanalysis Zone interview, Graeme Dennis (IDBS) discusses the biggest emerging trends in scientific data management and what the future looks like for IDBS.